Navigation Links
Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results
Date:8/7/2008

08 170,730,621 Receivables from stockholders (50,000 ) (50,000 ) Accumulated deficit (146,892,807 ) (139,847,326 ) Accumulated other comprehensive (loss) income (864,981 ) 157,531 Total stockholders' equity 23,566,919 31,034,754 Total liabilities and stockholders' equity $ 32,264,741 $ 39,775,021 INOVIO BIOMEDICAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months EndedJune 30, Six Months EndedJune 30, 2008 2007 2008 2007 Revenue: License fee and milestone payments $ 203,924 $ 209,265 $ 396,753 $ 443,754 Revenue under collaborative research anddevelopment arrangements

459,110 286,312 919,295 534,302 Grant and miscellaneous revenue — — — 21,423 Total revenue 663,034 495,577 1,316,048 999,479 Operating expenses: Research and development 1,679,264 2,907,836 3,276,652 5,424,247 General and administrative 3,086,180 2,344,551 5,487,685 4,635,712 Total operating expenses 4,765,444 5,252,387 8,764,337 10,059,959 Loss from operations (4,102,410 ) (4,756,810 ) (7,448,289 ) (9,060,480 ) Interest income 191,371 286,792 490,120 509,860 Other income (expense) (112,733 ) 727,305 (87,312 ) 1,066,610 Net loss (4,023,772 ) (3,742,713 ) (7,045,481 ) (7,484,010 ) Imputed and declared dividends on preferredstock

— (8,244 ) — (23,335 ) Net loss attributable to common stockholders

  • (4,023,772 ) $ (3,750,957 ) $ (7,045,481 ) $ (7,507,345 ) Amounts per common share — basic and diluted:

Net loss per share attributable to common stockholders

  • (0.09 ) $ (0.09 ) $ (0.16 ) $ (0.19 ) Weighted average number of common shares outstanding — basic and diluted

43,874,739 40,674,947 43
'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
2. Nektar Therapeutics Announces Second Quarter 2008 Results
3. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
4. InteKrin Therapeutics Announces $20 Million Series C Financing
5. Transition Therapeutics Announces No Material Change
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
7. DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins
8. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
9. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
10. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
11. Horizon Therapeutics Names Timothy P. Walbert as President and CEO
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results 
(Date:9/23/2014)... York (PRWEB) September 23, 2014 Eight-week program, ... cystitis, pudendal neuralgia, and other chronic pelvic or sexual pain, ... relief. , According to the Gallup poll, 1 in 7 ... chronic pelvic pain. Many of those women suffer in ... healthcare providers. The type of pain varies from woman ...
(Date:9/23/2014)... 23, 2014 People across Minnesota acknowledge ... healthy choices, but barriers are more prominent in the ... The Center for Prevention at Blue Cross and Blue ... access to healthy, affordable food and a lack of ... easily. About 60 percent of rural Minnesotans who responded ...
(Date:9/23/2014)... 23, 2014). Researchers from the University of ... Krischek, investigated gene expression in normal vestibular nerves ... made: 1) there is negligible difference between VSs ... neurofibromatosis Type 2 (NF2), a genetic disorder; and ... tumors may be an excellent therapeutic target. Detailed ...
(Date:9/23/2014)... 2014 "Bee Towers” was featured on NewsWatch ... features the latest technology gadgets and services available to consumers. ... the tech review and shared with viewers how ... , Tablet sales rates in the United States continue to ... now own a tablet. , For consumers who own ...
(Date:9/23/2014)... September 23, 2014 Steven Winter Associates, ... firm’s recent projects in the State of Connecticut – ... Gateway at 570 – were honored by the Connecticut ... Awards held on September 18, 2014 at Stepping Stones ... High School, Bridgeport , Recipient of the Institutional Award ...
Breaking Medicine News(10 mins):Health News:Mind Body Expert Launches Pelvic Pain Relief Program 2Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 2Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 3Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 4Health News:Minnesota Health Poll: One State, Different Challenges, Unique Solutions 5Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 3Health News:“Bee Towers”, a Floor Standing Tablet Holder by XAR Motion, was Featured on NewsWatch, a National Television Show, This Month 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 3
... RE: American Psychological Association 116th Annual Convention in Boston, ... Meeting Level 1, Boston Convention and Exhibition Center. ... and two high-speed printers. We will also provide working ... and APA staff resources. This room will also be ...
... -- Are the health needs of women adequately addressed ... the May issue of Mayo Clinic Proceedings, a team ... question. , The traditional model of medical research was ... results of research on white male participants could be ...
... Spa This Summer, FONTANA, Wis., May 12 ... - June, 2008, is the latest enhancement to The ... of Lake Geneva, Wisconsin., The newly renamed AVANI ... evokes feelings of tranquility, peace, relaxation, and rebirth.,Utilizing inspiration ...
... student, teachers, EMT among winners with inspirational, ... educational ... Foundation of,America, in partnership with Procter & Gamble Pharmaceuticals (P&G), has,selected ... to honor, educate and inspire those affected by ulcerative,colitis. Winners, stories ...
... May 12 FutureScripts(R), the premier,pharmacy benefit manager ... http://www.futurescripts.com . The website is a valuable tool ... to find key,information about the drugs on FutureScripts, ... "The new website allows our customers to ...
... , Montreal, May 12, 2008 Losing a limb can ... physical pain can linger for years. To better understand the ... Emma Duerden is inviting amputees to come forward and share ... is to better understand why amputees retain the memory of ...
Cached Medicine News:Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 2Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 3Health News:Highlights for APA's 116th Annual Convention in Boston, Aug. 14-17 4Health News:Medical research should include more women participants and examine the role of gender in disease 2Health News:Medical research should include more women participants and examine the role of gender in disease 3Health News:The AVANI Spa Debuts at the Abbey Resort 2Health News:The AVANI Spa Debuts at the Abbey Resort 3Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 2Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 3Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 4Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 5Health News:UPDATE: Celebrating UC Success Announces Essay Contest Winners 6Health News:Pharmacy Benefit Manager FutureScripts(R) Launches New Website 2Health News:Pharmacy Benefit Manager FutureScripts(R) Launches New Website 3
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
... Farnsworth Dichotomous testing sets are designed ... The Farnsworth D15 test is used to ... Normal. The L'Anthony Desaturated test is much ... mild deficiency from Normal. Both of ...
... test is as easy as 1-2-3: just three ... patient satisfaction with rapid information before they leave ... immediately with the appropriate therapy; no more follow-up ... NOW® Strep A Test is a rapid immunochromatographic ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Medicine Products: